StockNews.com Initiates Coverage on Veradigm (NASDAQ:MDRX)

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX) in a research report sent to investors on Monday. The brokerage issued a hold rating on the software maker’s stock.

A number of other equities research analysts have also issued reports on MDRX. TD Cowen reduced their target price on Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a research note on Tuesday, May 28th. Deutsche Bank Aktiengesellschaft reissued a hold rating and set a $10.00 price target (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th. Five equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of Hold and an average target price of $12.00.

Veradigm Stock Up 1.1 %

MDRX stock opened at $9.50 on Monday. Veradigm has a 1 year low of $5.01 and a 1 year high of $14.09. The stock’s 50 day moving average price is $8.17 and its 200 day moving average price is $8.82.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. TFO Wealth Partners LLC lifted its stake in shares of Veradigm by 105,280.0% during the 4th quarter. TFO Wealth Partners LLC now owns 5,269 shares of the software maker’s stock worth $52,000 after purchasing an additional 5,264 shares during the period. Gladius Capital Management LP raised its position in shares of Veradigm by 135.0% in the 4th quarter. Gladius Capital Management LP now owns 6,245 shares of the software maker’s stock worth $66,000 after buying an additional 3,587 shares during the period. Meadow Creek Wealth Advisors LLC purchased a new position in shares of Veradigm in the 1st quarter worth $83,000. Headlands Technologies LLC raised its position in shares of Veradigm by 14,907.7% in the 4th quarter. Headlands Technologies LLC now owns 9,755 shares of the software maker’s stock worth $102,000 after buying an additional 9,690 shares during the period. Finally, Covestor Ltd raised its position in shares of Veradigm by 10.3% in the 3rd quarter. Covestor Ltd now owns 10,336 shares of the software maker’s stock worth $136,000 after buying an additional 966 shares during the period.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.